[4/28]
WHO ±Û·Î¹ú COVID-19 ¿ªÇÐ µ¿Çâ
(COVID-19 Global Epidemiological Update )
¼¼°èº¸°Ç±â±¸ COVID-19 Highlights
ÁÖ¿ä ±¹°¡º° COVID-19 È®ÁøÀÚ, Ä¡¸í·ü ¹× ¿ÏÄ¡À²(2020.0428)
ÇöÀç Àü¼¼°èÀûÀ¸·Î 211°³±¹¿¡¼ COVID-19·Î ÀÎÇÑ È®ÁøÀÚ´Â3,022,511¸í, »ç¸ÁÀÚ 211,224¸íÀ¸·Î ÇöÀç±îÁö Ä¡¸íÀ²(CFR)Àº 6.99%¸¦ ³ªÅ¸³»°í ÀÖ´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ ÀÇÇÑ ÁÖ¿ä Áö¿ªº° È®ÁøÀÚ ¹× Ä¡¸í·ü(CFR)Àº ¾Æ·¡¿Í °°´Ù.
Ç¥ 1 ) ¼¼°è Áö¿ªº° COVID-10 È®ÁøÀÚ, Ä¡¸í·ü (WHO Situation Report-98)
±¸ºÐ
|
À¯·´
|
¾Æ¸Þ¸®Ä«
|
µ¿ºÎÁöÁßÇØ
|
¼ÅÂÆò¾ç
|
µ¿³²¾Æ½Ã¾Æ
|
¾ÆÇÁ¸®Ä«
|
È®ÁøÀÚ(¸í)
|
1,359,380
|
1,140,520
|
165,933
|
144,121
|
46,060
|
2,1470
|
»ç¸ÁÀÚ(¸í)
|
124,525
|
58,492
|
6,991
|
5,958
|
1,824
|
865
|
Ä¡¸í·ü(CFR)
|
9.16%
|
5.13%
|
4.21%
|
4.13%
|
3.96%
|
4.02%
|
±×¸² 1) COVID-19 È®Áø ±¹°¡ ¹× Áö¿ªº° È®Áø »ç·Ê(2020³â4¿ù27ÀÏÀÚ WHO º¸°í)
Source: WHO Coronavirus disease 2019 (COVID-19) Situation Report -98 [¹Ù·Î°¡±â]
Ç¥ 2) ±¹°¡ ¹× Áö¿ªº° COVID-19 È®Áø ÇöȲ(2020³â 4¿ù27ÀÏÀÚ WHO º¸°í)
Source: WHO Coronavirus disease 2019 (COVID-19) Situation Report 98
±×¸² 3) COVID-19 È®Áø ¿ªÇа(³¯Â¥º°, Áö¿ªº° 2020³â 4¿ù27ÀÏÀÚ)
Source: WHO Coronavirus disease 2019 (COVID-19) Situation Report 98
[Ãֽŵ¿Çâ] Coronavirus 2019 (COVID-19)] Highlights
F1. [±¹³»Ç÷ÀåÄ¡·á¼º°ø] COVID-19: ¿ÏÄ¡ÀÚ Ç÷ÀåÄ¡·á(Convalescent Plasma)
±¹³» ¼¼ºê¶õ½ºº´¿ø ¿¬±¸ÆÀÀº ¿ÏÄ¡ÀÚ Ç÷Àå(Convalescent Plasma) Ä¡·á¹æ¹ýÀ¸·Î ÀÓ»ó¿¡¼ Coronavirus disease 2019 (COVID-19)ÀÇ ¿ÏÄ¡ »ç·Ê¸¦ º¸°íÇß´Ù. ÀÌ°ÍÀº Çѱ¹¿¡¼ COVID-19¿¡ ´ëÇÑ ¿ÏÄ¡ÀÚ Ç÷Àå Ä¡·á¿¡ ´ëÇÑ Ã¹ ¹ø° ÀÓ»ó ¿ÏÄ¡»ç·ÊÀÌ´Ù. [»ó¼¼ ´õº¸±â]
F2. COVID-19 Ä¡·áÁ¦ ±ÝÁö :À̺ÎÇÁ·ÎÆæ(Ibuprofen), ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁ¦(NSAIDs)
ÀÇÇÐ Àú³Î ¶õ¼Â(The Lancet Respiratory Medicine)Àº À̺ÎÇÁ·ÎÆæÀ» Æ÷ÇÔÇÑ ÀϺΠ¾àÇ°ÀÌ °íÇ÷¾ÐÀ̳ª ´ç´¢º´À» ¾Î´Â COVID-19 ȯÀÚ¿¡°Ô À§ÇèÇÒ ¼ö ÀÖ´Ù´Â °¡¼³À» ¹ßÇ¥Çß´Ù. À̺ÎÇÁ·ÎÆæÀº ºñ½ºÅ×·ÎÀ̵强 Ç׿°ÁõÁøÅëÁ¦·Î, ÁøÅëÁ¦³ª ÇØ¿Á¦·Îµµ ¾²ÀδÙ. ‘¶õ¼Â È£Èí±âÀÇÇÐ(Lancet Respiratory Medicine)’¿¡¼ ¸¶ÀÌŬ ·Î½º(Michael Roth) ¹ÙÁ©ÀÇ´ë ±³¼ö´Â À̺ÎÇÁ·ÎÆæÀ» º¹¿ëÇϸé COVID-19ÀÇ ÁÖ¿ä ħÅõ °æ·ÎÀΠǥÀû ´Ü¹éÁú ACE2°¡ ¼¼Æ÷¿¡ °ú´Ù ¹ßÇöµÅ COVID-19ÀÇ ÁßÁõµµ ¶Ç´Â °¨¿° À§ÇèÀ» ³ôÀÏ ¼ö ÀÖÀ½À» ¹àÇû´Ù. [»ó¼¼ ´õº¸±â]
F3. COVID-19 Ä¡·áÁ¦°³¹ß ±Û·Î¹ú Àӻ󿬱¸ ÇÁ·ÎÁ§Æ®ÇöȲ
½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(Äڷγª19) Ä¡·áÁ¦ °³¹ßÀ» À§ÇØ Àü¼¼°è°¡ ³ë·ÂÇÏ°í ÀÖ´Â °¡¿îµ¥, ÇöÀç Äڷγª 19 Ä¡·áÁ¦ °³¹ß°ú °ü·Ã ±¹Á¦ÀûÀ¸·Î Àӻ󿬱¸°¡ 335,815°ÇÀÌ ÁøÇà Áß¿¡ ÀÖ´Ù(2020³â 4¿ù 13ÀÏÀÚ µî·ÏÇöȲ). ¹Ì±¹ ±¹¸³º¸°Ç¿ø NIH ClinicalTrials.gov¿¡ µî·ÏµÇ¾î ÁøÇàÇÏ°í ÀÖ´Â COVID-19 °ü·Ã Àӻ󿬱¸´Â 300¿©°Ç ÀÌ»óÀÌ ÁøÇà Áß¿¡ ÀÖÀ¸¸ç, ¼¼°èº¸°Ç±â±¸(WHO)±¹Á¦Àӻ󿬱¸µî·Ï Ç÷§Æû(World Health Organization's International Clinical Trials Registry Platform, WHO ICTRP)¿¡¼´Â 590°ÇÀÇ ÇÁ·ÎÁ§Æ®°¡ ÇöÀç Àӻ󿬱¸ Áß¿¡ ÀÖ´Ù. [»ó¼¼ ´õº¸±â]
Ç¥ 3) ÃֽŠÇмúÁ¤º¸ »çÀÌÆ® ¹Ù·Î°¡±â COVID-19
Ç¥4) ±¹³» ¹× ±¹¿Ü Äڷγª°¨¿°-19(COVID-19) ÃÖ±Ù ¾÷µ¥ÀÌÆ® Á¤º¸ ¹Ù·Î°¡±â
ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ Á¦°ø